R Bassan, T Lerede, G Borleri, B Chiodini, A Rossi, M Buelli, A Rambaldi, P Viero, T Barbui. Phase I trial with escalating doses of idarubicin and multidrug resistance reversal by short-course cyclosporin A, sequential high-dose cytosine arabinoside, and granulocyte colony-stimulating factor for adult patients with refractory acute leukemia. Haematologica 2002;87(3):257-263; https://doi.org/10.3324/%x.